TriSalus Life Sciences
TLSI
Insider trades and stock quote 2024-2026
All insider trades at TriSalus Life Sciences
| Date |
Type |
Insider |
Position |
Ø-Price |
Volume |
|
5/15/2026
|
Buy |
Gordon, Gary B. |
Director |
$2.5 |
$24,600 |
|
5/15/2026
|
Buy |
Patience, David |
Chief Financial Officer |
$2.4 |
$17,253 |
|
5/15/2026
|
Buy |
Szela, Mary T. |
CEO and President |
$2.6 |
$102,776 |
|
5/15/2026
|
Buy |
Stansky, Michael P. |
Director |
$2.5 |
$1,525,000 |
|
5/15/2026
|
Buy |
Wahlstrom, Mats |
Director |
$2.5 |
$151,800 |
|
5/15/2026
|
Sell |
Marshak, Richard |
Chief Commercial Officer |
$2.7 |
$1,450 |
|
3/17/2026
|
Sell |
Szela, Mary T. |
CEO and President |
$3.8 |
$61,384 |
|
3/16/2026
|
Sell |
Stevens, Jennifer |
Chief Regulatory Officer |
$4.1 |
$3,189 |
|
3/16/2026
|
Sell |
Marshak, Richard |
Chief Commercial Officer |
$4.1 |
$1,726 |
|
3/16/2026
|
Sell |
Cox, Bryan F. |
Chief of Research |
$4.1 |
$2,385 |
|
3/16/2026
|
Sell |
Devlin, Jodi |
Chief of Clinical Operations |
$4.1 |
$1,125 |
|
3/12/2026
|
Sell |
Stevens, Jennifer |
Chief Regulatory Officer |
$4.1 |
$6,348 |
|
3/12/2026
|
Sell |
Marshak, Richard |
Chief Commercial Officer |
$4.1 |
$6,499 |
|
3/12/2026
|
Sell |
Cox, Bryan F. |
Chief of Research |
$4.1 |
$6,000 |
|
3/12/2026
|
Sell |
Devlin, Jodi |
Chief of Clinical Operations |
$4.1 |
$7,247 |
|
3/11/2026
|
Sell |
Szela, Mary T. |
CEO and President |
$4.1 |
$17,999 |
|
3/11/2026
|
Sell |
Stevens, Jennifer |
Chief Regulatory Officer |
$4.1 |
$4,973 |
|
3/11/2026
|
Sell |
Marshak, Richard |
Chief Commercial Officer |
$4.1 |
$5,984 |
|
3/11/2026
|
Sell |
Cox, Bryan F. |
Chief of Research |
$4.1 |
$4,700 |
|
3/11/2026
|
Sell |
Devlin, Jodi |
Chief of Clinical Operations |
$4.1 |
$4,799 |
|
2/23/2026
|
Buy |
Stansky, Michael P. |
Director |
$4.1 |
$1,480,502 |
|
2/23/2026
|
Buy |
Szela, Mary T. |
CEO and President |
$4.1 |
$124,997 |
|
2/23/2026
|
Buy |
Valle, William |
Director |
$4.1 |
$124,997 |
|
2/23/2026
|
Buy |
Gordon, Gary B. |
Director |
$4.1 |
$40,000 |
|
2/23/2026
|
Buy |
Patience, David |
Chief Financial Officer |
$4.1 |
$14,994 |
|
5/19/2025
|
Sell |
Stevens, Jennifer |
Chief Regulatory Officer |
$5.2 |
$45,087 |
|
5/19/2025
|
Sell |
Marshak, Richard |
Chief Commercial Officer |
$5.2 |
$34,172 |
|
5/19/2025
|
Sell |
Devlin, Jodi |
Chief of Clinical Operations |
$5.2 |
$24,678 |
|
5/19/2025
|
Sell |
Cox, Bryan F. |
Chief of Research |
$5.2 |
$24,678 |
|
2/5/2025
|
Buy |
Young, James Emmett |
Chief Financial Officer |
$5.6 |
$33,900 |
|
1/30/2025
|
Buy |
Szela, Mary T. |
CEO AND PRESIDENT |
$5.3 |
$26,453 |
|
1/29/2025
|
Buy |
Szela, Mary T. |
CEO AND PRESIDENT |
$5.0 |
$25,301 |
|
1/28/2025
|
Buy |
Murphy, Sean |
Chief Manuf, Strategy&Bus Dev. |
$5.2 |
$77,550 |
|
1/28/2025
|
Buy |
Szela, Mary T. |
CEO AND PRESIDENT |
$5.1 |
$24,146 |
|
1/27/2025
|
Buy |
Young, James Emmett |
Chief Financial Officer |
$5.4 |
$129,600 |
|
1/27/2025
|
Buy |
Murphy, Sean |
Chief Manuf, Strategy&Bus Dev. |
$5.3 |
$79,650 |
|
1/27/2025
|
Buy |
Szela, Mary T. |
CEO AND PRESIDENT |
$5.4 |
$26,157 |
|
12/17/2024
|
Buy |
Frankenius, Equity Ab |
Ten Percent Owner |
$4.0 |
$249,999 |
|
12/10/2024
|
Sell |
Desai, Arjun Jj |
Director |
$3.7 |
$110,700 |
|
11/22/2024
|
Buy |
Wahlstrom, Mats |
Director |
$4.6 |
$22,750 |
|
11/21/2024
|
Buy |
Wahlstrom, Mats |
Director |
$4.4 |
$38,570 |
|
11/20/2024
|
Buy |
Wahlstrom, Mats |
Director |
$4.2 |
$8,486 |
|
10/5/2024
|
Sell |
Cox, Bryan F. |
CHIEF SCIENTIFIC & MANUFACT. |
$4.4 |
$1,394 |
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)
Insidertrades in Telegram
Follow insider buying in real time via push in our Telegram channel.
Join now